ABVC BioPharma Inc.

AI Score

0

Unlock

0.72
0.03 (4.33%)
At close: Mar 03, 2025, 12:26 PM

ABVC BioPharma Income Statement

Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08 FY07 FY06 FY05 FY04 FY03 FY02
Revenue 152.43K 969.78K 355.8K 483.05K 701.72K 6.96K 3.2K 32.00 3.36K n/a 7.79K 5.71K 3.19K 14.86K -271.72K 25.09K 41.67K n/a n/a 57.49K 13.67K 10K
Cost of Revenue 302.04K 286.42K 5.09K 18.72K 20.14K 185.28K 2.25K 32.00 521.00 n/a n/a n/a n/a n/a 271.72K n/a n/a n/a n/a 32.39K 25.76K 10K
Gross Profit -149.61K 683.37K 350.71K 464.33K 681.58K -178.32K 947.00 n/a 2.84K n/a 7.79K 5.71K 3.19K 14.86K -543.44K 25.09K 41.67K n/a n/a 25.1K -12.09K n/a
Operating Income -8.22M -15.11M -11.35M -8.51M -3.46M -1.39M -1.99M -4.5M -32.28K -70 -177.26K -1.14M -1.89M -1.68M -4.91M -5.35M -4.42M -26.82K -17.57K 2.01K -23.8K -20K
Interest Income 185.48K 187.82K 43.2K 71.05K 23.34K 93.00 7.21K 361.00 n/a n/a n/a n/a n/a n/a 142.00 5.78K 20.94K 1.43K 1.21K 568.00 n/a n/a
Pretax Income -10.65M -15.51M -11.21M -10.81M -4.01M -4.1M -7.03M -4.51M -32.28K -70 -226.35K -1M -1.01M n/a -5.18M -6.77M n/a -25.4K -16.36K 2.54K -25.36K -20K
Net Income -10.52M -16.31M -12.04M -10.59M -3.93M -4.1M -5.05M -4.51M -32.28K -70 -226.35K -1.07M -1.22M -1.9M -5.18M -6.77M -4.65M -25.4K -26.67K 2.54K -25.36K -20K
Selling & General & Admin 7M 13.1M 11.05M 8.42M 3.09M 723.95K 1.74M 4.5M 35.12K n/a n/a n/a 1.89M 1.9M 4.91M 5.38M 4.46M 26.82K 17.57K 23.1K 11.72K 20K
Research & Development 1.06M 2.69M 1M 549.66K 1.05M 669.67K 256.68K 10M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Expenses n/a 83K -360.9K 199.64K 116.85K n/a 63.39K n/a 35.12K 70.00 185.05K 1.15M n/a -206.98K n/a n/a n/a n/a n/a n/a n/a -0.00
Operating Expenses 8.07M 15.8M 11.7M 8.97M 4.14M 1.39M 1.99M 4.5M 35.12K 70.00 185.05K 1.15M 1.89M 1.7M 4.91M 5.38M 4.46M 26.82K 17.57K 23.1K 11.72K 20K
Interest Expense 2.49M 293.97K 227.21K 405.03K 482.01K 155.93K 222.06K 10.17K n/a n/a 49.09K 87.7K 204.92K 218.57K 271.86K 1.42M 256.51K -1.43K -1.21K n/a 1.56K n/a
Selling & Marketing Expenses n/a n/a n/a n/a n/a 695.15K 1.74M 4.5M n/a n/a n/a n/a n/a n/a n/a 2.01M n/a n/a n/a n/a n/a n/a
Cost & Expenses 8.37M 16.08M 11.7M 8.99M 4.16M 1.39M 1.99M 4.5M 35.64K 70.00 185.05K 1.15M 1.89M 1.7M 4.91M 5.38M 4.46M 26.82K 17.57K 55.49K 37.47K 30K
Income Tax 256.01K 797.78K 825.02K -220.35K -77.04K 1.85K -360.39K 836.00 -1.89M n/a 49.09K 67.64K -1.75M 218.57K -142 -5.78K -20.94K -1.43K 9.1K -532 n/a n/a
Shares Outstanding (Basic) 4.34M 3.17M 2.51M 1.97M 1.75M 1.16M 170.67K 1.08M 87.27K 190.00 190.00 190.00 49.00 22.00 22.00 2.03K 3.67K 3.67K 3.67K 3.67K 22.00 28.61M
Shares Outstanding (Diluted) 4.34M 3.17M 2.51M 1.97M 1.75M 1.19M 170.67K 1.08M 87.27K 190.00 190.00 190.00 49.00 22.00 22.00 2.03K 3.67K 3.67K 3.67K 3.67K 22.00 28.61M
EPS (Basic) -2.43 -5.15 -4.8 -5.37 -2.25 -3.53 -29.58 -4.18 -0.37 -0.37 -1.19K -5.63K -24.87K -86.41K -235.55K -3.33K -1.27K -6.93 -7.28 0.69 -1.15K -0.00
EPS (Diluted) -2.43 -5.15 -4.8 -5.37 -2.25 -3.45 -29.58 -4.18 -0.37 -0.37 -1.19K -5.63K -24.87K -86.41K -235.55K -3.33K -1.27K -6.93 -7.28 0.69 -1.15K -0.00
EBITDA -8.13M -15.2M -10.97M -10.37M -3.47M -2.74M -4M 561.00 -32.28K -70 -153.4K -881.2K -979.55K -1.64M -4.87M -5.31M -4.4M -26.82K -17.57K -14.6K -23.8K -20K
Depreciation & Amortization 28.53K 23.8K 11.99K 37.14K 55.09K 43.61K 44K 11M 1.89M n/a 23.86K 33.05K 34.18K 45.25K 45.08K 37.49K 12.76K n/a n/a 36.00 n/a n/a